Search Results
Brentuximab vedotin: current status and future considerations for this agent in HL treatment
Treatment options for patients with Hodgkin lymphoma who progress after brentuximab vedotin
Current indications for the use of brentuximab vedotin in Hodgkin lymphoma
Updates on the use of brentuximab vedotin in later-stage HL
SGN35-027: Brentuximab vedotin with nivolumab, doxorubicin, and dacarbazine in HL
Brentuximab vedotin, nivolumab, doxorubicin & dacarbazine for early stage classical Hodgkin lymphoma
Real-world efficacy of brentuximab vedotin as consolidation therapy in patients with HL
The current role of chemotherapy in the treatment of Hodgkin lymphoma & the impact of novel agents
The Impact of Brentuximab Vedotin as PTCL Treatment
A Study of Brentuximab Vedotin Plus AVD in Hodgkin Lymphoma
Hodgkin Lymphoma: Using Brentuximab Vedotin Frontline
Toxicities associated with brentuximab vedotin in pediatric and adolescent Hodgkin lymphoma
